ArticleEndocrine, metabolic & immune disorders drug targets2026
Integrative eQTL and Mendelian Randomization Analyses with Experimental Validation Prioritize Genetic Candidate Biomarkers for Crohn's Disease.
Xinwei Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.